Displaying drugs 14276 - 14300 of 14671 in total
OSI-7904L
OSI-7904L is a liposome encapsulated thymidylate synthase inhibitor, which is indicated for use in advanced gastric and/or gastroesophageal adenocarcinoma (A-G/GEJA). Current treatments also inhibit thymidylate synthase but the innovative lipid coating of OSI-7904L allows for more enduring results with administration of the TS inhibitor.
Investigational
Matched Description: … liposome encapsulated thymidylate synthase inhibitor, which is indicated for use in advanced gastric and …
Seladelpar
Seladelpar (MBX-8025) has been used in trials studying the treatment of Hyperlipidemia.
Investigational
2,5-Dimethoxy-4-(n)-propylthiophenethylamine
Experimental
Illicit
Embutramide
Experimental
Illicit
4-Bromo-2,5-dimethoxyphenethylamine
Experimental
Illicit
R048-8071
Experimental
N-Cyclohexyl-N'-(4-Iodophenyl)Urea
Experimental
N-Butyl-Benzenesulfonamide
Experimental
3,5-Difluorobenzenesulfonamide
Experimental
4-iodo-acetamido phenylboronic acid
Experimental
PASBN
Experimental
Displaying drugs 14276 - 14300 of 14671 in total